The report provides key information about the company, its major products and brands. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. Co-Diagnostics is headquartered in Sandy, Utah, the US. Its technology is designed for new-generation mobile point-of-care diagnostic devices and commercially available devices. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its products find application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants among others. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)Ĭalendars and Economy: 'Actual' numbers are added to the table after economic reports are released.Speak directly to the analyst to clarify any post sales queries you may have. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.Ĭryptocurrencies: Cryptocurrency quotes are updated in real-time. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Data may be intentionally delayed pursuant to supplier requirements. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Source: FactSetĭata are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Tullett PrebonĬommodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Tullett PrebonĬurrencies: Currency quotes are updated in real-time. Sources: FactSet, Dow Jonesīonds: Bond quotes are updated in real-time. Sources: FactSet, Dow JonesĮTF Movers: Includes ETFs & ETNs with volume of at least 50,000. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.
Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright © FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx(R) Tech Program Announces Recent Grant AwardsĬo-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CAĬo-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and WebcastĬo-Diagnostics, Inc. Reports Second Quarter 2023 Financial ResultsĬo-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, ThailandĬo-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.Ĭo-Diagnostics, Inc. Grabar Law Office Investigates Claims on Behalf of Shareholders of Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer Wainwright 25th Annual Global Investment Conference on September 11-13, 2023Ĭo-Diagnostics, Inc.
CODX Significant News OnlyĬo-Diagnostics, Inc.
0 kommentar(er)
